A phase II/III study of cediranib and olaparib combination compared to cediranib or olaparib alone or standard of care chemotherapy, in platinum-resistant ovarian cancer (NRG-GY005)
Jung‐Min Lee,Brady Mark,Austin Miller,Richard G. Moore,Helen Mackay,Leah McNally,Jayanthi Lea,Stéphanie Lheureux,David A. Bender,Linda Duska,Guilherme Cantuaria,Juraj Kavecansky,Charles A. Leath,Matthew A. Powell,Mark G. Cadungog,Peter G. Rose,Michael A. Bookman,Elise C. Kohn,Angeles Alvarez Secord
PDF的下载单位、IP信息已删除
(2025-6-4)
科研通AI6.1
Twonej
风清扬
YifanWang
Criminology34
无极微光
Singularity
文艺的蜜蜂
BowieHuang
CAOHOU
执着谷兰
核桃
专注的问寒
滕祥
shisui
asdfzxcv
Ky_Mac
小青椒
飞翔的霸天哥
wanci
lcc
tuanheqi
子车茗
HOAN
皖公网安备34019202002308
